Recombinant Human Serum Albumin(Protgen)
重组人血清白蛋白（普罗吉）
Report date: 2026/03/11 20:02:12
Base Information
Drug NameRecombinant Human Serum Albumin(Protgen)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShenzhen Protgen Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesProtgen LtdShenzhen Protgen Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A